38
Views
5
CrossRef citations to date
0
Altmetric
Review

The adoption of tobacco dependence treatment by rehabilitation clinicians

, &
Pages 147-155 | Accepted 01 Aug 2004, Published online: 07 Jul 2009

References

  • Centers for Disease Control and Prevention. Annual smok- ing-attributable mortality, years of potential life lost, and economic costs – United States, 1995 – 1999. Morbidity and Mortality Weekly Report 2002a; 51(14):300–303.
  • Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions among adults- United States, 1999. Morbidity and Mortality Weekly Report 2001; 50(7):120–125.
  • Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2000. Morbidity and Mortality Weekly Report 2002b; 51(29):642–645.
  • Iezzoni LI, McCarthy EP, Davis RB, Siebens H. Mobility impairments and use of screening and preventive services. American Journal of Public Health 2000; 90: 955–961.
  • McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001; 40: 640–644.
  • Spungen AM, Lesser M, Almenoff PL, Bauman WA. Prevalence of cigarette smoking in a group of male veterans with chronic spinal cord injury. Military Medicine 1995;160: 308– 311.
  • Jones GC, Bell K. Health and Employment Among Adults with Disabilities. Data brief. Washington, DC: NRH Center for Health and Disability Research, 2003.
  • Brawarsky P, Brooks DR, Wilber N, Gertz RE, Jr, Klein Walker D. Tobacco use among adults with disabilities in Massachusetts. Tobacco Control 2002;11(Suppl. II): ii29–ii33.
  • Beange H, McElduff A, Baker W. Medical disorders of adults with mental retardation: A population study. Amer- ican Journal on Mental Retardation 1995; 99: 595–604.
  • Burtner AP, Wakham MD, McNeal DR, Garvey TP. Tobacco and the institutionalized mentally retarded: Usage choice and ethical considerations. Special Care Dentistry 1995; 15: 56–60.
  • Tracy J, Hosken R. The importance of smoking education and preventative health strategies for people with intellectual disability. Journal of Intellectual Disability Research 1997; 41(5):416–421.
  • US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Georgia. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promo- tion, Office on Smoking and Health; 2000a.
  • Gerben D. Primary care for persons with disabilities supplement. Introduction: an overview of the problem. American Journal of Physical Medicine and Rehabilitation 1997;76(Suppl. 3):2–8.
  • Almenoff PL, Spungen AM, Lesser M, Bauman WA. Pulmonary funciton survey in spinal cord injury: Influences of smoking and level and completeness of injury. Lung 1995; 173(5):297–306.
  • Austin D. Disabilities are risk factors for late stage or poor prognosis cancers. Presented at Changing Concepts of Health and Disability. Bethesda, MD. Retrieved from http://www.healthwellness.org/training/training_conference. htm on January 26, 2004, March 17 – 18, 2003.
  • Casetta I, Granieri E, Malagu S, et al. Environmental risk facotrs and multiple sclerosis: A community-based, case- control study in the province of Ferrara, Italy. Neuroepide- miology 1994; 13: 120–128.
  • Fowler G. Tobacco and cardiovascular disease: Achieving smoking cessation. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gerish BJ (editors) Evidence based cardiology. London: BMJ Books; 1998. pp. 179–190.
  • Linn WS, Spungen AM, Gong Jr, H, Bauman WA, Adkins RH, Waters RL. Smoking and obstructive lung dysfunction in persons with chronic spinal cord injury. Journal of Spinal Cord Medicine 2003; 26(1):28 – 35.
  • National Multiple Sclerosis Society. The MS Information Sourcebook. Retrieved from http://www.nationalmssocie- ty.org/Sourcebook.asp on September 2, 2003.
  • Palmer KT, Syddall H, Cooper C, Coggon D. Smoking and musculoskeletal disorders: Findings from a British national survey, 2003.
  • Perkin GD, Bowden P, Rose FC. Smoking and optic neuritis. Postgraduate Medical Journal 1975; 51: 382–385.
  • Simpson CA, Newell DJ, Schapira K. Smoking and multiple sclerosis. Neurology 1966; 16: 1041–1043.
  • Sopori MF, Kozak W. Immunomodulatory effects of cigarette smoke. Journal of Neuroimmunology 1998;83: 148– 156.
  • Wilber N, Mitra M, Walker DK, Allen D, Myers AR, Tupper P. Disability as a public health issue: Findings and reflections form the Massachusetts Survey of Secondary Conditions. The Mibank Quarterly 2002; 80(2):393–421.
  • Eriksen W, Natvig B, Rutle O, Bruusgaard D. Smoking as a predictor of long-term work disability in physically active and inactive people. Occupational Medicine 1998; 48(5):315–320.
  • Franklin GM, Nelson L. Environmental risk factors in multiple sclerosis. Causes, triggers, and patient autonomy. Neurology 2003; 61: 1032–1034.
  • Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. American Journal of Epide- miology 2001; 154(1):69–74.
  • Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global burden of disease study. Lancet 1997; 349(9064):1498–1504.
  • Ostbye T, Taylor HD, Jung H. A longitudinal study of the effects of tobacco smoking and other modifiable risk factors on ill health in middle-aged and old Americans: Results from the health and retirement study and asset and health dynamics among the oldest old survey. Preventive Medicine 2002; 34(3):334–345.
  • Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003; 61: 1122–1124.
  • Lacasse Y, Goldstein RS. Smoking cessation in comprehen- sive pulmonary rehabilitation [letter]. Lancet 1997;349:285.
  • Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348: 1115– 1119.
  • Young P, Dewse M, Fergusson W, Kolbe J. Respiratory rehabilitation in chronic obstructive pulmonary disease: Predictors of nonadherence. European Respiratory Journal 1999; 13: 855–859.
  • Branigan M, Stewart DE, Tardif GS, Veltman A. Percep- tions of primary healthcare services among persons with physical disabilities. Part 2: Quality issues, 2001. Retrieved from http://www.medscape.com/viewarticle/408123_print on January 28, 2004.
  • Bak S, Sindrup SH, Alslev T, Kristensen O, Christensen K, Gaist D. Cessation of smoking after first-ever stroke. A follow-up study. Stroke 2002; 33(9):2263–2269.
  • Joseph LN, Babikian VL, Allen NC, Winter MR. Risk factor modification in stroke prevention: The experience of a stroke clinic. Stroke 1999; 30: 16–20.
  • Renfren J, McKevitt C, Dundas R, Rudd AG, Wolfe CD. Behavioural risk factor prevalence and lifestyle change after stroke. Stroke 2000; 31: 1877–1881.
  • Patel-Larson A. Literature review of smoking among persons with disabilities. Paper presented at the National Conference on Tobacco or Health. San Francisco, CA, 2002. Retrieved from: http://ncth.confex.com/ncth/responses/2002/2 on Jan- uary 20, 2004.
  • Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Heyman RB, Jaen CR, Kottke TE, Lando HA, Mecklenburg RE, Mullen PD, Nett LM, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, Maryland: U.S. Department of Health and Human Services, Public Health Service, 2000.
  • Ashenden R, Silagy C, Weller D. A systematic review of the effectiveness of promoting lifestyle change in general practice. Family Practice 1997; 14(2):160–175.
  • Gilpin EA, Pierce JP, Johnson M, Bal D. Physician advice to quit smoking: Results from the 1990 California Tobacco Survey. Journal of General Internal Medicine 1993; 8: 549–553.
  • Silagy C, Stead LF. Physician advice for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd; 2004.
  • Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation (Cochrane Re- view). In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd; 2004.
  • Stead LF, Lancaster T. Individual behavioural counseling for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd; 2004.
  • Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. Journal of the American Medical Association 1999; 281: 72–76.
  • Leischow S, Muramototo ML, Cook G, Merikle E, Castellini S, Otte PS. OTC nicotine patches: effectiveness alone and with brief intervention. American Journal of Health Behavior 1999; 23(1):61–69.
  • Swartz SH, Ellsworth AJ, Curry SJ, Boyko EJ. Community patterns of transdermal nicotine use and provider counsel- ing. Journal of General Internal Medicine 1995; 10: 656–662. A. Bobo JK, McIlvain HE, Lando HA, Walker RD, Leed-Kelly Effect of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community inter- vention trial. Addiction 1998; 93(6):877–887.
  • Breslau N, Peterson E, Schultz L, Andreski P, Chilcoat H. Are smokers with alcohol disorders less likely to quit? American Journal of Public Health 1996; 86(7): 985 – 990.
  • Burling TA, Burling AS, Latini D. A controlled smoking cessation trial for substance-dependent inpatients. Journal of Counseling and Clinical Psychology 2001; 69(2):295–304.
  • Campbell BK, Wander N, Stark MJ, Holbert T. Treating cigarette smoking in drug-abusing clients. Journal of Sub- stance Abuse Treatment 1995; 12(2): 89 – 94.
  • Clarke JG, Stein MD, McGarry KA, Gogineni A. Interest in smoking cessation among injection drug users. American Journal of the Addictions 2001; 10(2):159–166.
  • Frosch DL, Shoptaw S, Nahorn D, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Ex- perimental and Clinical Psychopharmacology 2000; 8(1): 97– 103.
  • Frosch DL, Stein JA, Shoptaw S. Using latent-variable models to analyze smoking cessation clinical trial data: an example among the methadone maintained. Experimental and Clinical Psychopharmacology 2002; 10(3):258–267.
  • Leed-Kelly A, Russell KS, Bobo JK, McIlvain H. Feasibility of smoking cessation counseling by phone with alcohol treatment center graduates. Journal of Substance Abuse Treatment 1996; 13(3):203–210.
  • Rohsenow DJ, Monti P, Colby S, Martin R, Abrams D, Sirota A. Brief interventions for smoking cessation in alcoholic smokers. Alcoholism Clinical and Experimental Research 2002; 26(12):1950–1951.
  • Saxon AJ, McGuffin R, Walker RD. An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol- and drug-dependent inpatients. Journal of Substance Abuse Treatment 1997; 14(4):333–337.
  • Burling TA, Marshall GD, Seidner AL. Smoking cessation for substance abuse inpatients. Journal of Substance Abuse 1991; 3: 269–276.
  • Hurt RD, Eberman KM, Croghan IT. Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial. Alcoholism: Clinical and Experimental Research 1994; 18: 867–872.
  • Joseph AM, Nichol KL, Anderson H. Effect of treatment for nicotine dependence on alcohol and drug treatment out- comes. Addictive Behaviors 1993; 18: 635–644.
  • American College of Chest Physicians/American Association of Cardiovascular and Pulmonary Rehabilitation. Pulmonary Rehabilitation Guidelines Panel. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based guidelines. Chest 1997; 112: 1363–1396.
  • Emmons KM, Goldstein MG. Smokers who are hospita- lized: A window of opportunity for cessation interventions. Preventive Medicine 1992; 21: 262–269.
  • Guilmette TJ, Motta SI, Shadel WG, Mukand J, Niaura R. Promoting smoking cessation in the rehabilitation setting. American Journal of Physical Medicine and Rehabilitation 2001; 80(8):560–562.
  • Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O’Hara P, et al. for the Lung Study Health Research GroupEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV: The Lung Health Study. Journal of the American Medical Association 1994; 272: 1497–1505.
  • Hajek P, Taylor TZ, Mills P. Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: Randomised controlled trial. British Medical Journal 2002; 324(7329): 87– 89.
  • Jimenez-Ruiz CA, Masa F, Miravtilles M, et al. Smoking characteristics: Differences in attitudes and dependence between health smokers and smokers with COPD. Chest 2001; 119: 1365–1370.
  • van Elderen-van Kemenade T, Maes S, van den Broek Y. Effects of a health education programme with telephone follow-up during cardiac rehabilitation. British Journal of Clinical Psychology 1994;33(Pt 3):367–378.
  • US Department OF Health and Human Services. Healthy People 2010: Understanding and improving health. 2nd ed. Washington, DC: US Government Printing Office, 2000b.
  • Friend K, Levy D. Smoking treatment interventions and policies to promote their use. Nicotine and Tobacco Research 2001; 3(4):299–310.
  • Friend KB, Levy DT. Adoption of tobacco treatment interventions by substance abuse clinicians. Drugs: Educa- tion Prevention & Policy 2004; 11(1): 1 – 20.
  • Centers for Disease Control and Prevention. Healthy People 2010. Retrieved from www.healthypeople.gov on February 4, 2004, 2003a.
  • Doescher MP, Saver BG. Physicians’ advice to quit smoking: The glass remains half empty. Family Practice 2000; 49(6):543–547.
  • National Committee for Quality Assurance. The state of managed care quality, 2001 [WWW document]. Retrieved from http://www.ncqa.org/somc2001/ADVISE_SM/SOM- C_2001_ADVISE_SM.html on June 3, 2002.
  • Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, Atkins D, Richland JH, Haddix A. Priorities among recommended clinical preventive ser- vices. American Journal of Preventive Medicine 2001; 21(1): 1– 9.
  • Centers for Disease Control and Prevention. Missed opportunities in prevention counseling for cardiovascular disease. Morbidity and Mortality Weekly Report 1995; 47 (5):91– 95.
  • McIlvain HE, Backer EL, Crabtree BF, Lacy N. Physician attitudes and the use of office-based activities for tobacco control. Family Medicine 2002; 34(2):114–119.
  • Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. Journal of the American Medical Association 1998;279: 604– 605.
  • Gil BS, Bennett DC. Addiction professionals’ attitudes regarding treatment of nicotine dependence. Journal of Substance Abuse Treatment 2000; 19(4):317–318.
  • Goldstein MG, Niaura R, Willey-Lessne C, DePue J, Eaton C, Rakowski W, Dube C. A population-based survey of patients’ perceptions of health care provider-delivered smoking cessation interventions. Archives of Internal Med- icine 1997; 157: 1313–1319.
  • Goldstein MG, Depue JD, Monroe AD, Lessne CW, Rakowski W, Prokhorov A, Niaura R, Dube CE. A population-based survey of physician smoking cessation counseling practices. Preventive Medicine 1998; 27: 720–729.
  • Hahn EJ, Warnick TA, Plemmons S. Smoking cessation in drug treatment programs. Journal of Addictive Diseases 1999; 18(4): 89 – 101.
  • Kottke TE, Solberg LI, Brekke ML, Cabera A, Marquez MA. Delivery rates for preventive services in 44 mid- western clinics. Mayo Clinic Proceedings 1997; 72: 515–523.
  • McIlvain HE, Bobo JK, Leed-Kelly A, Sitorisu MA. Practical steps to smoking cessation for recovering alcoholics. American Family Physician 1998; 57(8):1879–1882.
  • Bobo JK, Gilchrist LD. Urging the alcoholic client to quit smoking cigarettes. Addictive Behaviors 1983; 8(3):297–305.
  • Bobo JK, Slade J, Hoffman AL. Nicotine addiction counsel- ing for chemically dependent patients. Psychiatric Services 1995; 46(9):945–947.
  • Agency for Healthcare Research and Quality. Cardiac rehabilitation beneficial but under-used, say new AHCPR Guidelines, 1995. Press release. Rockville, MD. Retrieved from http://www.ahrq.gov/news/press/prs12.htm on February 7, 2004.
  • Centers for Disease Control and Prevention. Receipt of cardiac rehabilitation services among heart attack survivors- 19 states and the District of Columbia, 2001. Morbidity and Mortality Weekly Report 2003b; 52(44):1072–1075.
  • Coyle CP, Santiago MC. Healthcare utilization among women with physical disabilities. Medscape Women’s Health 2002; 7(4): 2.
  • Iezzoni LI, McCarthy EP, Davis RB, Harris-David L, O’Day B. Use of screening and preventive services among women with disabilities. American Journal of Medical Quality 2001; 16(4):135–144.
  • Nosek MA, Howland CA. Breast and cervical cancer screening among women with physical disabilities. Archives of Physical Medicine and Rehabilitation 1997;78(12, Suppl. 5): S39–S44.
  • Schootman M, Jette DB. Identifying factors associated with disability-related differences in breast cancer screening (United States), 2003.
  • Stein K, Allen N. Cross sectional survey of cervical cancer screening in women with learning disability. British Medical Journal 1999;318:641.
  • Centers for Disease Control and Prevention. Receipt of advice to quit smoking in Medicaid managed care-United States, 1998. Morbidity and Mortality Weekly Report 2000; 49(35):797–801.
  • Bock BC, Becker B, Monteiro R, Partridge R, Fisher S, Spencer J. Physician intervention and patient risk perception among smokers with acute respiratory illness in the emergency department. Preventive Medicine 2001; 32(2): 175– 181.
  • Basford JR, Rohe DE, Barnes CP, DePompolo RW. Substance abuse attitudes and policies in US rehabilitation training programs: A comparison of 1985 and 2000. Archives of Physical Medicine and Rehabilitation 2002; 83: 517–521.
  • Bickford LS, Hodgkin JE, McInturff WL. National pulmon- ary rehabilitation survey: Update. Journal of Cardiopul- monary Rehabilitation 1995; 15: 406–411.
  • Cohen SJ, Christen AG, Katz BP, Drook CA, Davis BJ, Smith DM, Stookey GK. Counseling medical and dental patients about cigarette smoking: The impact of nicotine gum and chart reminders. American Journal of Public Health 1987; 77: 313–316.
  • Cornuz J, Ghali WA, Di Carlantonio D, Pecoud A, Paccaud F. Physicians’ attitudes towards prevention: Importance of intervention-specific barriers and physicians’ health habits. Family Practice 2000; 17(6):535–540.
  • Glynn TJ, Manley MW, Pechacek TF. Physician-initiated smoking cessation program: the National Cancer Institute trials. Progress in Clinical and Biological Research 1990; 339: 11–25.
  • Lindsay EA, Wilson DM, Best JA, Willms DG, Singer J, Gilbert JR, Taylor DW. A randomized trial of physician training for smoking cessation. American Journal of Health Promotion 1989; 3: 11–18.
  • Strecher VJ, Kreuter M, Den Boer DJ, Kobrin S, Hospers HJ, Skinner CS. The effects of computer-tailored smoking cessation messages in family practice settings. Journal of Family Practice 1994; 39: 262–270.
  • Tremblay M, Gervais A, Lacroix C, O’Loughlin H, Makni H, Paradis G. Physicians taking action against smoking: An intervention program to optimize smoking cessation coun- seling by Montreal general practitioners. Cmaj: Canadian Medical Association Journal 2001; 165(5):601–607.
  • Ahluwalia JS, Gibson CA, Kenney RE, Wallace DD, Resnicow K. Smoking status as a vital sign. Journal of General Internal Medicine 1999; 14(7):402–408.
  • Amundson G, Solberg LI, Reed M, Martini EM, Carlson R. Paying for quality improvement: Compliance with tobacco cessation guidelines. Joint Commission Journal on Quality and Safety 2003; 29(2):59–65.
  • Cooke M, Mattick RP, Lesley B. Predictors of brief smoking intervention in a midwifery setting. Addiction 1996; 91(11): 1715– 1725.
  • Davis DA, Thomson MA, Oxman AD, Haynes B. Changing physician performance: A systematic review of the effect of continuing medical education strategies. Journal of the American Medical Association 1995; 274: 700–705.
  • Goodwin MA, Zyzanski SJ, Zronek S, Ruhe M, Weyer SM, Konrad N, Esola D, Stange KC. A clinical trial of tailored office systems for preventive service delivery. The Study to Enhance Prevention by Understanding Practice (STEP-UP). American Journal of Preventive Medicine 2001; 21(1):20–28.
  • Katz DA, Muehlenbruch DR, Brown RB, Fiore MC, Baker TB. Effectiveness of a clinic-based strategy for implementing the AHRQ smoking cessation guideline in primary care. Preventive Medicine 2002; 35(3):293–301.
  • Levy DT, Friend K. The effects of clean indoor air laws: What do we know and what do we need to know? Health Education Research 2003; 18(5):592–609.
  • Logsden DN, Lozarro CM, Meier RV. The feasibility of behavioral risk reduction in primary medical care. American Journal of Preventive Medicine 1989; 5(5):246–259.
  • Milch CE, Edmunson JM, Beshansky JR, Griffith JL, Selker HP. Smoking cessation in primary care: A clinical effective- ness trial of two simple interventions. Preventive Medicine 2004; 38(3):284–294.
  • Roski J, Jeddeloh R, An L, Lando H, Hannan P, Hall C, Zhu SH. The impact of financial incentives and a patient registry on preventive care quality: Increasing provider adherence to evidence-based smoking cessation practice guidelines. Pre- ventive Medicine 2003; 36(3):291–299.
  • Davis RM. Healthcare report cards and tobacco measures. Tobacco Control 1997;6(Suppl. 1):S70 – S77.
  • Davis RM. An overview of tobacco measures. Tobacco Control 1998;7(Suppl.): i36–i40.
  • Orleans CT, Abrams DB, Gruman JC. Will healthcare take tobacco addiction seriously? Using policy to drive practice. Medscape General Medicine 2001; 3(2): 15.
  • Solberg LI. Incentivising, facilitating, and implementing an office tobacco cessation system. Tobacco Control 2001;9(Supp. 1): i37–i41.
  • Bentz CJ. Implementing tobacco tracking codes in an individual practice association or a network model health maintenance organization. Tobacco Control 2000;9(Supp. 1):142 – 145.
  • Piper ME, Fiore MC, Smith SS, Jorenby DE, Wilson JR, Zehner ME, Baker TB. Use of the vital sign stamp as a systematic screening tool to promote smoking cessation. Mayo Clinic Proceedings 2003; 78(6):716–722.
  • Hurt RD, Croghan IT, Offord KP, Eberman KM, Morse RM. Attitudes toward nicotine dependence among chemical dependency unit staff-Before and after a smoking cessation trial. Journal of Substance Abuse Treatment 1995; 12(4):247 – 252.
  • Perine JL, Schare ML. Effect of counselor and client education in nicotine addiction on smoking in substance abuse. Addictive Behaviors 1999; 24(3):443–447.
  • Zullino D, Besson J, Schnyder C. Stage of change of cigarette smoking in alcohol-dependent patients. European Addiction Research 2000; 6(2):84–90.
  • Cabana MD, Rand CS, Rowe NR, Wu AW, Wilson MH, Abboud PC, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. Journal of the American Medical Association 1999; 282(15):1458–1465.
  • Capretto NA. Confronting nicotine dependency at the Gateway Rehabilitation Center. Journal of Substance Abuse Treatment 1993; 10: 113–136.
  • Fishman ML, Earley PH. Treatment centers: The next challenge. The Counterpoint Unit at CPC Parkwood Hospital. Journal of Substance Abuse Treatment 1993;10: 133– 137.
  • Goldberg RJ, Ockene IS, Ockene JK, Merriam P, Kristeller J. Physicians’ attitudes and reported practices toward smoking intervention. Journal of Cancer Education 1993; 8(2):133–139.
  • Knapp JM, Rosheim CL, Meister EA. Managing tobacco dependence in chemical dependency treatment facilities: A survey of current attitudes and policies. Journal of Addictive Disease 1993; 12(4):89–104.
  • Kotz MM. A smoke-free chemical dependency unit. The Cleveland Clinic Experience. Journal of Substance Abuse Treatment 1993; 10: 125–131.
  • Rigotti NA, Quinn VP, Stevens VJ, Solberg LI, Hollis JF, Rosenthal AC, Zapka JG, France E, Gordon N, Smith S, Monroe M. Tobacco-control policies in 11 leading managed care organizations: Progress and challenges. Effective Clin- ical Practice 2002; 5(3):130–136.
  • Campbell BK, Krumenacker J, Stark MJ. Smoking cessation for clients in chemical dependence treatment: A demonstra- tion project. Journal of Substance Abuse Treatment 1998; 15(4):313–318.
  • Lacasse Y, Maltais F, Goldstein RS. Smoking cessation in pulmonary rehabilitation: Goal or prerequisite? Journal of Cardiopulmonary Rehabilitation 2002; 22: 148–153.
  • Goldstein M, Niaura R. Smoking. In: E Topol (editor) Textbook of Cardiovascular Medicine. Philadelphia, PA: Lippincott-Raven, 1998; pp. 145–169.
  • Kottke TE. Attributes of successful smoking interventions in medical practice: A meta-analysis of 39 controlled trials. Journal of the American Medical Association 1998;259: 2883– 2889.
  • Centers for Disease Control and Prevention. State laws on tobacco control—United States, 1998. Morbidity and Mortality Weekly Report 1999;48(SS-3):21–62.
  • Curry SJ, Ludman EJ. Tobacco and alcohol interventions in health maintenance organizations: principles and challenges for a public health perspective. In: Ferttig JB, Allen JP (editors) Alcohol and Tobacco: From Basic Science to Clinical Practice, NIAAA Research Monograph No. 30. NIH Pub. No. 95-3931. Washington, DC: Supt. of Docs., U.S. Govt. Print. Office, 1995; pp. 295–306.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.